• Investing
  • Stock
Round Table Thoughts
  • Economy
  • Editor’s Pick
Home Investing Jefferies analyst reveals his top two biotech stocks for 2023
Investing

Jefferies analyst reveals his top two biotech stocks for 2023

by December 28, 2022
by December 28, 2022 0 comment
Share
0
FacebookTwitterPinterestWhatsapp

Moderna Inc (NASDAQ: MRNA) has tanked nearly 15% in recent days but a Jefferies analyst dubs it one of his best ideas for 2023.

Moderna stock could climb another 50%

Earlier in December, the biotech company said its candidate vaccine for skin cancer showed encouraging results in a Phase II study (read more). That’s what Michael Yee is most bullish about.  

I think that story will continue to unfold in 2023. Partner Merck is very bullish on this programme and opening up a lot of studies, including in lung cancer. So, it’s the first chapter and an important development.

The Nasdaq-listed firm will soon report Phase III data for its experimental RSV vaccine as well. Yee sees that as another reason to buy Moderna stock.  

He now sees upside in “MRNA” to $275 – up another 50% from here.

Yee is also bullish on the Amgen stock

A legacy name within “biotech” that pops out to Jefferies’ Michael Yee is Amgen Inc (NASDAQ: AMGN) that’s already up more than 15% for the year. Explaining why on CNBC’s “Closing Bell”, he said:

A more defensive large biotech company like Amgen is quite attractive in this difficult environment. [Also] in an offensive position where a renaissance of pipeline that has been going under appreciated.

The analyst is also constructive on its obesity drug currently named “AMG133” that was recently shown to have promising durability. Yee values the market for obesity drug at $20 billion to $50 billion.  

Earlier this month, Amgen Inc revealed plans of buying Horizon Therapeutics Plc for nearly $28 billion.

The post Jefferies analyst reveals his top two biotech stocks for 2023 appeared first on Invezz.

You Might Also Like
  • GameStop trends ahead of earnings. But this Wedbush rating spells trouble for the stock
  • American Airlines lifts Q4 guidance on ‘strong demand’
  • Top features of NinjaSpread
  • 12 Tips For Building Long-Term Wealth
Share
0
FacebookTwitterPinterestWhatsapp

previous post
This is what you should expect from U.S. stocks in Q1 of 2023
next post
Galaxy to acquire Helios Bitcoin mining facility from Argo Blockchain

You may also like

What made Logitech shares lose 20% on Thursday?

January 12, 2023

Should you buy Walgreens stock on market-beating Q1 results?

January 6, 2023

Should you buy the euro amid ECB’s Schnabel keeping a...

November 25, 2022

Chesapeake Energy stock has ‘tremendous upside’ despite falling natural gas...

January 5, 2023

U.S. Fed lifts rates by 50 basis points

December 14, 2022

Stock market soars as inflation comes in below expectations

December 13, 2022

Fed’s preferred inflation gauge eased further in November

December 23, 2022

Unilever may be considering selling its U.S. ice cream brands

December 8, 2022

Lloyds share price outlook for December 2022

December 1, 2022

Jim Cramer disagrees with Jamie Dimon on recession

December 6, 2022

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Recent Posts

    • Breakouts, Momentum & Moving Averages: 10 Must-See Stock Charts Right Now

      May 31, 2025
    • Leadership Rotation Could Confirm Corrective Phase

      May 30, 2025
    • Run Your Stock Portfolio Like a Pro Sports Team

      May 30, 2025
    • U.S. foreign tax bill sends jitters across Wall Street

      May 30, 2025
    • Amazon taps Xbox co-founder to lead new team developing ‘breakthrough’ consumer products

      May 30, 2025

    Popular Posts

    • 1

      Trump-era China sanctions ended by Biden may be...

      June 27, 2024 2,765 views
    • 2

      Walz’s honeymoon with China gets fresh scrutiny as...

      August 9, 2024 2,472 views
    • 3

      Biden appointee played key role in recruiting Chinese...

      June 25, 2024 2,451 views
    • 4

      Shein’s global ambitions leaves some cybersecurity experts fearful...

      July 10, 2024 2,432 views
    • 5

      Harris VP pick spent years promoting research facility...

      August 29, 2024 2,308 views

    Categories

    • Economy (7,009)
    • Editor's Pick (2,106)
    • Investing (538)
    • Stock (2,581)

    Popular Posts

    • 1

      Trump-era China sanctions ended by Biden may be revived under new House GOP bill

      June 27, 2024
    • 2

      Walz’s honeymoon with China gets fresh scrutiny as Harris camp blasts ‘lying’ critics

      August 9, 2024
    • 3

      Biden appointee played key role in recruiting Chinese businesses to Delaware: ‘Longtime friends’

      June 25, 2024
    • 4

      Shein’s global ambitions leaves some cybersecurity experts fearful of Chinese spy threats

      July 10, 2024
    • 5

      Harris VP pick spent years promoting research facility that collaborated with ‘Chinese military company’

      August 29, 2024

    Latest News

    • Breakouts, Momentum & Moving Averages: 10 Must-See Stock Charts Right...

      May 31, 2025
    • Leadership Rotation Could Confirm Corrective Phase

      May 30, 2025
    • Run Your Stock Portfolio Like a Pro Sports Team

      May 30, 2025

    Categories

    • Economy (7,009)
    • Editor's Pick (2,106)
    • Investing (538)
    • Stock (2,581)

    Disclaimer: RoundTableThoughts.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2024 RoundTableThoughts.com. All Rights Reserved.

    Round Table Thoughts
    • Investing
    • Stock
    Round Table Thoughts
    • Economy
    • Editor’s Pick

    Read alsox

    GameStop saw a big increase in...

    December 7, 2022

    Boeing lands the largest order for...

    December 13, 2022

    Cramer shares outlook on Amgen after...

    December 12, 2022
    Sign In

    Keep me signed in until I sign out

    Forgot your password?

    Password Recovery

    A new password will be emailed to you.

    Have received a new password? Login here